Cargando…

Is vascular remodelling in patients with chronic heart failure exaggerated?

BACKGROUND: Vascular remodelling of large arteries increases afterload of the left ventricle. The aim of this study was to analyse whether vascular remodelling and function under laboratory and 24‐hour ambulatory conditions is impaired in patients with chronic heart failure (CHF) independently of ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Pietschner, Robert, Bosch, Agnes, Kannenkeril, Dennis, Striepe, Kristina, Schiffer, Mario, Achenbach, Stephan, Schmieder, Roland E., Kolwelter, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871653/
https://www.ncbi.nlm.nih.gov/pubmed/36193013
http://dx.doi.org/10.1002/ehf2.14174
_version_ 1784877225587245056
author Pietschner, Robert
Bosch, Agnes
Kannenkeril, Dennis
Striepe, Kristina
Schiffer, Mario
Achenbach, Stephan
Schmieder, Roland E.
Kolwelter, Julie
author_facet Pietschner, Robert
Bosch, Agnes
Kannenkeril, Dennis
Striepe, Kristina
Schiffer, Mario
Achenbach, Stephan
Schmieder, Roland E.
Kolwelter, Julie
author_sort Pietschner, Robert
collection PubMed
description BACKGROUND: Vascular remodelling of large arteries increases afterload of the left ventricle. The aim of this study was to analyse whether vascular remodelling and function under laboratory and 24‐hour ambulatory conditions is impaired in patients with chronic heart failure (CHF) independently of cardiovascular risk factors. METHODS AND RESULTS: In this monocentric cross‐sectional observational study, 105 patients with CHF and an ejection fraction ≤49% (CHF+) were compared to 118 subjects without CHF (CHF−). After adjustment for age, gender, arterial hypertension, hyperlipidaemia, type 2 diabetes, obesity and smoking, vascular function and structure parameters, as assessed by pulse wave analysis (SphygmoCor) and the UNEX EF device, respectively, between the CHF+ and the CHF− group differed for resting pulse wave velocity (PWV) (P = 0.010), 24‐h ambulatory PWV (P = 0.011), central systolic blood pressure (cSBP) (P = <0.001), 24‐h ambulatory cSBP (P = <0.001), resting central augmentation index (P = 0.002), and brachial intima–media thickness (P = 0.022). In CHF+ patients, higher levels of NT‐proBNP, taken as a marker for the severity of CHF, were related to a higher PWV (r = 0.340, P = <0.001), a higher cSBP (r = 0.292, P = 0.005), and a trend to higher central pulse pressure (cPP) (r = 0.198, P = 0.058), higher 24‐h brachial PP (r = 0.322, P = 0.002), and 24‐h total peripheral resistance (s = 0.227, P = 0.041) after full adjustment for covariates. CONCLUSIONS: In CHF+ patients we observed augmented vascular remodelling and functional impairment compared with CHF− patients independently of cardiovascular risk factors, age, and gender, and the extent of vascular remodelling and impairment was related to the severity of CHF.
format Online
Article
Text
id pubmed-9871653
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98716532023-01-25 Is vascular remodelling in patients with chronic heart failure exaggerated? Pietschner, Robert Bosch, Agnes Kannenkeril, Dennis Striepe, Kristina Schiffer, Mario Achenbach, Stephan Schmieder, Roland E. Kolwelter, Julie ESC Heart Fail Original Articles BACKGROUND: Vascular remodelling of large arteries increases afterload of the left ventricle. The aim of this study was to analyse whether vascular remodelling and function under laboratory and 24‐hour ambulatory conditions is impaired in patients with chronic heart failure (CHF) independently of cardiovascular risk factors. METHODS AND RESULTS: In this monocentric cross‐sectional observational study, 105 patients with CHF and an ejection fraction ≤49% (CHF+) were compared to 118 subjects without CHF (CHF−). After adjustment for age, gender, arterial hypertension, hyperlipidaemia, type 2 diabetes, obesity and smoking, vascular function and structure parameters, as assessed by pulse wave analysis (SphygmoCor) and the UNEX EF device, respectively, between the CHF+ and the CHF− group differed for resting pulse wave velocity (PWV) (P = 0.010), 24‐h ambulatory PWV (P = 0.011), central systolic blood pressure (cSBP) (P = <0.001), 24‐h ambulatory cSBP (P = <0.001), resting central augmentation index (P = 0.002), and brachial intima–media thickness (P = 0.022). In CHF+ patients, higher levels of NT‐proBNP, taken as a marker for the severity of CHF, were related to a higher PWV (r = 0.340, P = <0.001), a higher cSBP (r = 0.292, P = 0.005), and a trend to higher central pulse pressure (cPP) (r = 0.198, P = 0.058), higher 24‐h brachial PP (r = 0.322, P = 0.002), and 24‐h total peripheral resistance (s = 0.227, P = 0.041) after full adjustment for covariates. CONCLUSIONS: In CHF+ patients we observed augmented vascular remodelling and functional impairment compared with CHF− patients independently of cardiovascular risk factors, age, and gender, and the extent of vascular remodelling and impairment was related to the severity of CHF. John Wiley and Sons Inc. 2022-10-03 /pmc/articles/PMC9871653/ /pubmed/36193013 http://dx.doi.org/10.1002/ehf2.14174 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Pietschner, Robert
Bosch, Agnes
Kannenkeril, Dennis
Striepe, Kristina
Schiffer, Mario
Achenbach, Stephan
Schmieder, Roland E.
Kolwelter, Julie
Is vascular remodelling in patients with chronic heart failure exaggerated?
title Is vascular remodelling in patients with chronic heart failure exaggerated?
title_full Is vascular remodelling in patients with chronic heart failure exaggerated?
title_fullStr Is vascular remodelling in patients with chronic heart failure exaggerated?
title_full_unstemmed Is vascular remodelling in patients with chronic heart failure exaggerated?
title_short Is vascular remodelling in patients with chronic heart failure exaggerated?
title_sort is vascular remodelling in patients with chronic heart failure exaggerated?
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871653/
https://www.ncbi.nlm.nih.gov/pubmed/36193013
http://dx.doi.org/10.1002/ehf2.14174
work_keys_str_mv AT pietschnerrobert isvascularremodellinginpatientswithchronicheartfailureexaggerated
AT boschagnes isvascularremodellinginpatientswithchronicheartfailureexaggerated
AT kannenkerildennis isvascularremodellinginpatientswithchronicheartfailureexaggerated
AT striepekristina isvascularremodellinginpatientswithchronicheartfailureexaggerated
AT schiffermario isvascularremodellinginpatientswithchronicheartfailureexaggerated
AT achenbachstephan isvascularremodellinginpatientswithchronicheartfailureexaggerated
AT schmiederrolande isvascularremodellinginpatientswithchronicheartfailureexaggerated
AT kolwelterjulie isvascularremodellinginpatientswithchronicheartfailureexaggerated